Search research articles
Contact Us
Filters
Showing results (1-10 of 5) with videos related to
Page
of 1
Sort By:
Clinical Chemistry and Laboratory Medicine
|
April 6, 2004
Testing and validating a homogeneous immunometric assay for interference
Johan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Clinical Biochemistry
|
April 12, 2005
Human heterophilic antibodies display specificity for murine IgG subclasses
Johan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Clinical Chemistry
|
March 20, 2002
Immunometric assay interference: incidence and prevention
Johan Bjerner, Kjell Nustad, Lars F Norum, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 24, 2010
TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins
Elisabeth Paus, Mads Haugland Haugen, Kari Hauge Olsen, et al.
Annals of Surgical Oncology
|
February 23, 2017
Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
Ida S Frøysnes, Yvonne Andersson, Stein G Larsen, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 5) with videos related to
Sort By:
Page
of 1
Clinical Chemistry and Laboratory Medicine
|
April 6, 2004
Testing and validating a homogeneous immunometric assay for interference
Johan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Clinical Biochemistry
|
April 12, 2005
Human heterophilic antibodies display specificity for murine IgG subclasses
Johan Bjerner, Kari Hauge Olsen, Ole P Børmer, et al.
Clinical Chemistry
|
March 20, 2002
Immunometric assay interference: incidence and prevention
Johan Bjerner, Kjell Nustad, Lars F Norum, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|
July 24, 2010
TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins
Elisabeth Paus, Mads Haugland Haugen, Kari Hauge Olsen, et al.
Annals of Surgical Oncology
|
February 23, 2017
Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial
Ida S Frøysnes, Yvonne Andersson, Stein G Larsen, et al.
Page
of 1